… Obese Patients As mentioned previously, data have shown that fixed doses of fondaparinux
are effective in obese patients. For VTE treatment in patients weighing more than 100 kg, a …

… 2.5 直接口服抗凝药 直接口服抗凝药(direct oral anticoagulant,DOAC), 即新型口服抗凝药(new
oral anticoagulant,NOAC), 是近年来新出现的选择性凝血因子抑制剂,主要包括以 达比加群为…

… C21)15 was used to assess the negative emotional states of subjects, including depression,
… to me very much, or most of the time”) was used to rate the extent to which subjects had …

… oral anticoagulants, together with the increased ability to accurately stratify patients … it
potentially feasible and safe to manage selected low-risk patients in the outpatient setting …

… The new oral anticoagulants: Reasonable alternatives to warfarin[J]. Cleve Clin J Med,
2015, 82(12): 847-854 [14] Primignani M, Tosetti G, La Mura V. Therapeutic and clinical aspects …

… Good quality of life in severely obese total knee replacement patients: a casecontrol study[J]…
Hypoalbuminemia more than morbid obesity is an independent predictor of complications …

… The results of the study can be used in the physical culture instructor activities at the
organization of sports and recreational work in preschool educational institutions with recurrent …

… level of security use effectively.(14) Although this study has demonstrated HA extracts is
relatively safe within a certain dose range, further toxicological investigations are still needed. …

… Association Practical Guide on the use of non‑vitamin K antagonist oral anticoagulants in …
safety of direct oral antico‑ agulants versus warfarin in patients with atrial fibrillation across bmi …

… 例2: Objectives: To determine whether a computerized decision support system for initiation
and control of oral anticoagulant improves quality of anticoagulant control achieved by …